Expand BFRI Menu
BFRI MENU

BFRI Latest Press Releases

-- May 21, 2026 --

Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 Globe Newswire 9:15 AM

-- May 14, 2026 --

Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update Globe Newswire 7:30 AM

-- May 13, 2026 --

Biofrontera Launches Second Annual "Hats On" Campaign to Raise Awareness of Actinic Keratosis Globe Newswire 9:00 AM

-- May 8, 2026 --

Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026 Globe Newswire 4:00 PM

-- March 19, 2026 --

Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update Globe Newswire 9:25 AM

-- March 9, 2026 --

Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026 Globe Newswire 5:25 PM
Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz Photodynamic Therapy for moderate to severe Acne Vulgaris Globe Newswire 9:15 AM

-- February 26, 2026 --

U.S. Patent Office Issues Final Written Decision Finding All Challenged Claims of Sun Pharma's Patent 11,697,028 To Be Unpatentable Globe Newswire 9:15 AM

-- February 17, 2026 --

Biofrontera Inc. Announces Database Lock of Phase 1 Pharmacokinetics Study of Ameluz for Actinic Keratoses on Trunk and Extremities Globe Newswire 9:15 AM

-- February 11, 2026 --

Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz PDT in Superficial Basal Cell Carcinoma Globe Newswire 9:15 AM

-- February 9, 2026 --

Biofrontera Announces Positive Results in Phase 3 Study of Ameluz PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint Globe Newswire 9:15 AM
Market Data Delayed 15 Minutes